{
  "docId": "019de070-ca7e-71d0-9b6d-c6cccc832e2e",
  "docSlug": "61f4be21d1a97a93f2294133e3bf0c0f",
  "documentTitle": "Bausch Health Companies | Investor Conference Presentation Deck | 10 slides",
  "authorId": "bausch-health-companies",
  "authorName": "Bausch Health",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 7,
  "pageCount": 10,
  "prevPage": 6,
  "nextPage": 8,
  "slideType": "timeline",
  "function": "plan_implementation",
  "density": "dense",
  "nDataPoints": 1,
  "notes": "The slide outlines a drug development pipeline from preclinical to NDA submission.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-ca7e-71d0-9b6d-c6cccc832e2e/7",
  "deckHref": "/decks/019de070-ca7e-71d0-9b6d-c6cccc832e2e",
  "deckJsonHref": "/decks/019de070-ca7e-71d0-9b6d-c6cccc832e2e.json",
  "deckAnchorHref": "/decks/019de070-ca7e-71d0-9b6d-c6cccc832e2e#slide-7",
  "components": [
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.04,
        "y": 0.2
      },
      "kind": "list",
      "text": "Collaboration with Cedars-Sinai; Combination of rifaximin with a mucolytic agent (N-acetyl cysteine) to liberate bacteria for better kill rates.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0ae9693f-1e78-4c69-aa37-65bb443b3d5d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.9,
        "x": 0.04,
        "y": 0.48
      },
      "kind": "list",
      "text": "Preclinical completed; Proof of Concept 50% enrolled; Phase 2 start 2022; Phase 3 start 2023; NDA submission 2025.",
      "attrs": null,
      "subkind": "timeline-item",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "09887d21-6c60-49d4-acdb-da77d7b0df89",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.15,
        "x": 0.04,
        "y": 0.43
      },
      "kind": "title",
      "text": "Timeline",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "59818fb2-afa5-44f9-ab89-f5b0934d6586",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.8,
        "x": 0.025,
        "y": 0.04
      },
      "kind": "title",
      "text": "Combination of Rifaximin with a Mucolytic Agent",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "90b7c133-6043-47d0-8625-52506ca93fc9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.6,
        "x": 0.025,
        "y": 0.09
      },
      "kind": "title",
      "text": "Irritable Bowel Syndrome - Diarrhea Cedars-Sinai Collaboration",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "51c11f76-3303-49d3-b4bf-5bf0f42a5e8a",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "timeline",
      "slug": null,
      "matchId": "1502ee4e-7c35-4e5d-b2f8-3ba0c024f0e0",
      "evidence": "The slide explicitly labels a section 'Timeline' and lists sequential development milestones.",
      "confidence": 1
    }
  ],
  "arcBeats": [
    {
      "to": 9,
      "from": 7,
      "beatId": "bd5187b0-fc8d-4054-9227-e09f508a402c",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Solution",
      "beatSlug": "sequoia-pitch-solution",
      "evidence": "Rifaximin Liquid Gel Capsules, Rifaximin Timed Release Coated Beads in Capsules",
      "position": 2,
      "confidence": 0.6,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}